Search
for
Sort by
Research 61–90 of 910
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Alopecia Areata: Current Treatments and New Directions
- Urokinase is a Positive Regulator of Epidermal Proliferation In Vivo
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- Conditioned media obtained from human outer root sheath follicular keratinocyte culture activates signalling pathways that contribute to maintenance of hair-inducing capacity and increases trichogenicity of cultured dermal cells
- A review of Janus kinase inhibitor use in scarring alopecia
- Medical Dermatology
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study
- Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition
- JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease
- Complete responses and SALT zero scores in alopecia areata: not the same
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- A Novel Multimodal Approach in AAU Resistant to Conventional Therapies and Tofacitinib: A Case Report
- 75993 Safety of Janus kinase inhibitors for treatment of alopecia areata
- JAK-STAT pathway-associated skin diseases: a refined functional framework for inflammatory skin diseases
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Pharmacotherapy of alopecia areata
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Evolving treatment paradigms in dermatology: Insights from emerging and repurposed therapies
- 93 Approach to Managing Recalcitrant Alopecia Areata With Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- BH17 Bridging the gap: identifying dual-targeting therapies for patients with alopecia areata and coexisting immune-mediated inflammatory diseases
- Editor’s Picks June 2025
- Current options and treatment strategies for alopecia ateata in comorbidity with atopic diseases
- The Use of Janus Kinase Inhibitors for Primary Neutrophilic Cicatricial Alopecias
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- Modern dermatology brings treatment even for alopecia areata
- P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
- Drug news and therapeutic news
- <i>JAMA Dermatology—</i>The Year in Review, 2021